Antiemetic Studies on the NK₁ Receptor Antagonist Aprepitant

By Stoutenburg John P.   Raftopoulos Harry  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. : 491-497

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Aprepitant – a novel NK1-receptor antagonist

By Patel Lisa   Lindley Celeste  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2279-2296

Informa Healthcare

Access to resources Recommend Favorite

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

By Navari Rudolph M  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite

Opioid-Like Effects of the Neurokinin 1 Antagonist Aprepitant in Patients Maintained on and Briefly Withdrawn from Methadone

By Jones Jermaine D.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 86-91

Informa Healthcare

Access to resources Recommend Favorite

Antiemetic effects of sendide, a peptide tachykinin NK 1 receptor antagonist, in the ferret

By Minami M.   Endo T.   Kikuchi K.   Ihira E.   Hirafuji M.   Hamaue N.   Monma Y.   Sakurada T.   Tan-no K.   Kisara K.  

European Journal of Pharmacology, Vol. 363, Iss. 1, 1998-12 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite